Briya Expands Access to European Real-World Data Through Strategic Partnership with Casa Sollievo della Sofferenza

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

SAN GIOVANNI ROTONDO, Italy, March 4, 2025 /PRNewswire/ — Briya, a leading healthcare data retrieval network, is proud to announce a strategic partnership with Casa Sollievo della Sofferenza, one of Italy’s premier hospitals renowned for its advanced medical care and research initiatives. This collaboration marks a significant step in addressing a long-standing challenge in European medical research: the difficulty of accessing high-quality, real-world data (RWD) across the region.

Founded by Saint Pio of Pietrelcina and inaugurated on May 5, 1956, Casa Sollievo della Sofferenza (“Home for the Relief of Suffering”), is a private scientific research hospital located in San Giovanni Rotondo, Italy. Recognized for many years as one of the best Italian smart hospitals by the Newsweek ranking, the institution treats over 200,000 patients annually and is considered a relevant scientific research institution in Europe.

While RWD is increasingly essential for driving medical innovation, access to high-quality European data remains complex. This partnership addresses that gap by enabling global researchers to incorporate diverse Italian datasets into real-world evidence (RWE) studies, ultimately enhancing inclusion, refining clinical insights, and improving patient outcomes. Briya’s platform adheres to all local and global compliance regulations including the European GDPR and provides unparalleled access to European RWD. 

“We are thrilled to partner with Casa Sollievo della Sofferenza,” said David Lazerson, Co-Founder and CEO at Briya. “Their commitment to excel both in patient care and research aligns perfectly with our mission to accelerate innovation through data.” This partnership paves the way for increased ex-US RWD use, which is still in its infancy.”

Dr. Gino Gumirato, CEO of Casa Sollievo della Sofferenza, added, “Collaborating with Briya provides us with a unique opportunity. We can securely share and analyze data, and take part in groundbreaking discoveries. We are excited to lead the charge in enabling access to high-quality Real-World Data (RWD) from Italy.”

By bridging the gap between European data sources and global researchers, this partnership redefines the landscape of real-world evidence generation. It underscores a shared vision of unlocking the power of healthcare data to drive medical breakthroughs, not just in Italy, but worldwide.

About Briya

Briya is a leading healthcare data exchange network that provides rapid, secure, and frictionless access to patient-level clinical and real-world data. By retrieving, harmonizing, and standardizing data across global sources, Briya empowers health organizations, researchers, and life science companies to unlock the value of real-world data. Visit us at briya.com

About Casa Sollievo della Sofferenza

Casa Sollievo della Sofferenza (“Home for the Relief of Suffering”) is a private scientific research hospital owned by the Holy See and included in the national healthcare system, located in San Giovanni Rotondo, Italy. Founded by Saint Pio of Pietrelcina and inaugurated in 1956, it is recognized for its excellence in medical care and research. The hospital is considered a relevant scientific research institution in Europe.

Contact:
Mor Laila Pecht
mor.pecht@briya.com

View original content:https://www.prnewswire.com/news-releases/briya-expands-access-to-european-real-world-data-through-strategic-partnership-with-casa-sollievo-della-sofferenza-302390578.html

SOURCE Briya

Staff

Recent Posts

FinThrive Introduces Agentic AI at HFMA 2025 to Help Customers Transform Healthcare Revenue Cycle Management Performance

Company to also highlight advancements in denials and underpayments management and speak to the measurable…

7 hours ago

FinThrive Debuts Denials and Underpayments Analyzer, a Unified Solution for Denials and Underpayments, at HFMA 2025

Next generation analyzer helps hospitals protect revenue before it's lost by delivering timely end-to-end visibility…

7 hours ago

Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in New England Journal of Medicine

Data presented simultaneously at the American Diabetes Association’s® 85th Scientific Sessions, showed mean weight reduction…

10 hours ago

Dr. Anosh Ahmed Advances Chicago Crypto Hub Project as Federal Support for Blockchain Grows

Dr. Anosh Ahmed repurposes West Side warehouse into blockchain innovation center, targeting 250+ jobs and…

10 hours ago

Dr. Anosh Ahmed Advances Chicago Crypto Hub Project Amid National Pro-Crypto Policy Shift

Dr. Anosh Ahmed converts vacant West Side warehouse into blockchain innovation hub, creating 250+ jobs…

10 hours ago

BioAge Labs to Present Preclinical Data on APJ Agonism for Diabetic Obesity and Heart Failure at the American Diabetes Association (ADA) 85th Scientific Sessions

Treatment with apelin receptor agonist enhanced glycemic control and demonstrated cardioprotective effects, with additive benefits…

10 hours ago